Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey, 87542-87543 [2024-25580]

Download as PDF 87542 Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices • GQ(s) linked to their respective facility. The email for the GQ Administrators will contain the following information: Login information (GQ user ID), link to the Web GQAC questionnaire, instructions and overview, and pertinent dates such as the start and end dates of the Web-Based GQAC. The contact strategy for the Web GQAC is as follow: • Initial email will be sent to the GQ Administrator on February 2, 2026, the start date of the operation. • First reminder email for nonresponding GQs will be sent five (5) business days after the initial email. • Second reminder email for nonresponding GQs will be sent three (3) business days after the first reminder emails. • Third and final reminder email for nonresponding GQs will be sent three (3) business days after the second reminder emails. During In-Office GQAC, office clerks will call the GQ Administrator (using the phone number on file for the case or researching it using the internet) and conduct interviews while collecting responses and making entries into the clerk mode of the same secure GQAC data collection instrument used by GQ Administrators to verify and/or update the GQ information in preparation for conducting the upcoming enumeration operations. The In-Office GQAC phone operation will include the following: • Cases that did not meet the Web GQAC criteria stated above • Nonresponding cases from the Web GQAC • Email bounce backs from Web GQAC or non-responding contacts from the Web GQAC mailout. The contact strategy for the In-Office GQAC is as follow: • Three phone attempts: attempt 1, attempt 2, attempt 3 (final). • After the 3rd (final) attempt, case(s) will be assigned to the Census Field Supervisor to conduct an In-Field GQAC. lotter on DSK11XQN23PROD with NOTICES1 In-Field GQAC The In-Field GQAC visit operation will include all unresolved cases from the Web GQAC and In-Office GQAC. • Census workers will follow-up in the field with GQs for which preenumeration information such as contact information was not obtained. • Census workers will visit each identified GQ and conduct an in-person interview with the GQ contact person using an automated hand-held device to 17:28 Nov 01, 2024 Jkt 265001 OMB Control Number: 0607–XXXX. Form Number(s): D6–L–GA(ES), D6– CN–GA(ES), D6–E–GA(E/S). Type of Review: Regular submission. Affected Public: Administrators, primary and/or secondary contacts at Group Quarters facilities. Estimated Number of Respondents: 434. Estimated Time per Response: 30 minutes. Estimated Total Annual Burden Hours: 217. Estimated Total Annual Cost to Public: $0. Respondent’s Obligation: Mandatory. Legal Authority: Title 13 U.S.C. 141 and 193. We are soliciting public comments to permit the Department/Bureau to: (a) Evaluate whether the proposed information collection is necessary for the proper functions of the Department, including whether the information will have practical utility; (b) Evaluate the accuracy of our estimate of the time and cost burden for this proposed collection, including the validity of the methodology and assumptions used; (c) Evaluate ways to enhance the quality, utility, and clarity of the information to be collected; and (d) Minimize the reporting burden on those who are to respond, including the use of automated collection techniques or other forms of information technology. Comments that you submit in response to this notice are a matter of public record. We will include, or summarize, each comment in our request to OMB to approve this ICR. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you may ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Sheleen Dumas, Departmental PRA Clearance Officer, Office of the Under Secretary for Economic Affairs, Commerce Department. [FR Doc. 2024–25592 Filed 11–1–24; 8:45 am] BILLING CODE 3510–07–P PO 00000 Frm 00006 DEPARTMENT OF COMMERCE Foreign-Trade Zones Board III. Data IV. Request for Comments In-Office GQAC VerDate Sep<11>2014 capture the same information collected during Web GQAC and In-Office GQAC. Fmt 4703 Sfmt 4703 [B–56–2024] Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey Merck, Sharp & Dohme LLC submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Rahway, New Jersey, within Subzone 49Y. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on October 18, 2024. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/ component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished product(s) and material(s)/component(s) would be added to the production authority that the Board previously approved for the operation, as reflected on the Board’s website. The proposed finished products for research and development include MK– 2828 and MK–3214 cardiovascular disease drug products, MK–2420 autoimmune disease drug product, MK– 4646 HIV drug product, and MK–0472 oncology drug product (duty free). The proposed foreign-status materials/components include MK– 2828 and MK–3214 cardiovascular disease active pharmaceutical ingredients (API), MK–2420 autoimmune disease API, MK–4646 HIV API, and MK–0472 oncology API (duty rate, 6.5%). The request indicates that certain materials/components are subject to duties under section 301 of the Trade Act of 1974 (section 301), depending on the country of origin. The applicable section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is December 16, 2024. E:\FR\FM\04NON1.SGM 04NON1 Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Diane Finver at Diane.Finver@trade.gov. Dated: October 30, 2024. Elizabeth Whiteman, Executive Secretary. [FR Doc. 2024–25580 Filed 11–1–24; 8:45 am] BILLING CODE 3510–DS–P International Trade Administration [A–560–840] Aluminum Extrusions From Indonesia: Final Affirmative Determination of Sales at Less Than Fair Value; Correction Enforcement and Compliance, International Trade Administration, Department of Commerce. AGENCY: Notice; correction. The U.S. Department of Commerce (Commerce) published notice in the Federal Register of October 3, 2024 in which Commerce announced the final determination of the less-than-fair-value (LTFV) investigation of aluminum extrusions from Indonesia for the period of investigation (POI), October 1, 2022, through September 30, 2023. This notice corrects the language in the ‘‘Continuation of Suspension of Liquidation’’ section of the Final Determination. SUMMARY: FOR FURTHER INFORMATION CONTACT: Samuel Brummitt, AD/CVD Operations, Office III, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482–7851. SUPPLEMENTARY INFORMATION: lotter on DSK11XQN23PROD with NOTICES1 DOC case No. A–423–814 A–580–899 A–559–808 A–791–824 A–469–819 A–570–095 A–570–104 ...... ...... ...... ...... ...... ...... ...... On October 3, 2024, Commerce published in the Federal Register the final determination of the LTFV investigation of aluminum extrusions from Indonesia investigation.1 In that notice, we failed to include language regarding the suspension of liquidation of provisional measures in the companion countervailing duty (CVD) case in the ‘‘Continuation of Suspension of Liquidation’’ section. In the Federal Register of October 3, 2024, in FR Doc 2024–22780, on page 80489, in the first column, add the following sentence at the end of the ‘‘Continuation of Suspension of Liquidation’’ section: ‘‘However, suspension of liquidation of provisional measures in the companion CVD case has been discontinued; 2 therefore, we are not instructing CBP to collect cash deposits based upon the adjusted estimated weighted-average dumping margin for those export subsidies at this time.’’ Notification to Interested Parties This notice is issued and published in accordance with sections 735(d) and 777(i) of the Tariff Act of 1930, as amended, and 19 CFR 351.210(c). Dated: October 29, 2024. Abdelali Elouaradia, Deputy Assistant Secretary for Enforcement and Compliance. [FR Doc. 2024–25581 Filed 11–1–24; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Background Commerce’s procedures for the conduct of Sunset Reviews are set forth in its Procedures for Conducting FiveYear (Sunset) Reviews of Antidumping and Countervailing Duty Orders, 63 FR 13516 (March 20, 1998) and 70 FR 62061 (October 28, 2005). Guidance on methodological or analytical issues relevant to Commerce’s conduct of Sunset Reviews is set forth in Antidumping Proceedings: Calculation of the Weighted-Average Dumping Margin and Assessment Rate in Certain Antidumping Duty Proceedings; Final Modification, 77 FR 8101 (February 14, 2012). International Trade Administration Initiation of Review Initiation of Five-Year (Sunset) Reviews In accordance with section 751(c) of the Act and 19 CFR 351.218(c), we are initiating the Sunset Reviews of the following antidumping and countervailing duty order(s) and suspended investigation(s): Enforcement and Compliance, International Trade Administration, Department of Commerce. AGENCY: ITC case No. Country Product 731–TA–1435 731–TA–1436 731–TA–1438 731–TA–1439 731–TA–1440 731–TA–1428 731–TA–1441 Belgium ............ Korea ................ Singapore ......... South Africa ...... Spain ................ China ................ China ................ Acetone (1st Review) ................................... Acetone (1st Review) ................................... Acetone (1st Review) ................................... Acetone (1st Review) ................................... Acetone (1st Review) ................................... Aluminum Wire and Cable (1st Review) ..... Carbon and Alloy Steel Threaded Rod (1st Review). 1 See Aluminum Extrusions from Indonesia: Final Affirmative Determination of Sales at Less Than Fair Value, 89 FR 80487 (October 3, 2024) (Final Determination). VerDate Sep<11>2014 In accordance with the Tariff Act of 1930, as amended (the Act), the U.S. Department of Commerce (Commerce) is automatically initiating the five-year reviews (Sunset Reviews) of the antidumping and countervailing duty (AD/CVD) order(s) and suspended investigation(s) listed below. The U.S. International Trade Commission (ITC) will publish notice of Institution of FiveYear Reviews which covers the same order(s) and suspended investigation(s). DATES: Applicable November 4, 2024. FOR FURTHER INFORMATION CONTACT: Commerce official identified in the Initiation of Review section below at AD/CVD Operations, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230. For information from the ITC, contact Mary Messer, Office of Investigations, U.S. International Trade Commission at (202) 205–3193. SUPPLEMENTARY INFORMATION: SUMMARY: Correction DEPARTMENT OF COMMERCE ACTION: Background 17:28 Nov 01, 2024 Jkt 265001 87543 Commerce contact 2 See Aluminum Extrusions from Indonesia: Preliminary Affirmative Countervailing Duty Determination and Alignment of Final Determination With the Final Antidumping Duty Determination, 89 FR 17405 (March 11, 2024); see also section 703(d) of the Act, which states that the PO 00000 Frm 00007 Fmt 4703 Sfmt 4703 Jacqueline Arrowsmith, (202) 482–5255. Jacqueline Arrowsmith, (202) 482–5255. Jacqueline Arrowsmith, (202) 482–5255. Jacqueline Arrowsmith, (202) 482–5255. Jacqueline Arrowsmith, (202) 482–5255. Jacqueline Arrowsmith, (202) 482–5255. Mary Kolberg, (202) 482–1785. provisional measures may not be in effect for more than four months, which in the companion CVD case is 120 days after the publication of the preliminary determination, or July 8, 2024 (i.e., last day provisional measures are in effect). E:\FR\FM\04NON1.SGM 04NON1

Agencies

[Federal Register Volume 89, Number 213 (Monday, November 4, 2024)]
[Notices]
[Pages 87542-87543]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25580]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-56-2024]


Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production 
Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for 
Research and Development); Rahway, New Jersey

    Merck, Sharp & Dohme LLC submitted a notification of proposed 
production activity to the FTZ Board (the Board) for its facility in 
Rahway, New Jersey, within Subzone 49Y. The notification conforming to 
the requirements of the Board's regulations (15 CFR 400.22) was 
received on October 18, 2024.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz. The proposed finished 
product(s) and material(s)/component(s) would be added to the 
production authority that the Board previously approved for the 
operation, as reflected on the Board's website.
    The proposed finished products for research and development include 
MK-2828 and MK-3214 cardiovascular disease drug products, MK-2420 
autoimmune disease drug product, MK-4646 HIV drug product, and MK-0472 
oncology drug product (duty free).
    The proposed foreign-status materials/components include MK-2828 
and MK-3214 cardiovascular disease active pharmaceutical ingredients 
(API), MK-2420 autoimmune disease API, MK-4646 HIV API, and MK-0472 
oncology API (duty rate, 6.5%). The request indicates that certain 
materials/components are subject to duties under section 301 of the 
Trade Act of 1974 (section 301), depending on the country of origin. 
The applicable section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is December 16, 
2024.

[[Page 87543]]

    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: October 30, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-25580 Filed 11-1-24; 8:45 am]
BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.